Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hans Heijst"'
Autor:
Sander J. van Tilburg, Charlotte E. Teunissen, Carolien C.H.M. Maas, Robin C.M. Thomma, Christa Walgaard, Hans Heijst, Ruth Huizinga, Pieter A. van Doorn, Bart C. Jacobs
Publikováno v:
EBioMedicine, Vol 102, Iss , Pp 105072- (2024)
Summary: Background: Neurofilament light chain (NfL) is a biomarker for axonal damage in several neurological disorders. We studied the longitudinal changes in serum NfL in patients with Guillain-Barré syndrome (GBS) in relation to disease severity,
Externí odkaz:
https://doaj.org/article/beecc3ad1a104468a4575f5c12ed9042
Autor:
Ingeborg E. van Zeggeren, Liora ter Horst, Hans Heijst, Charlotte E. Teunissen, Diederik van de Beek, Matthijs C. Brouwer
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Diagnosing central nervous system (CNS) infections quickly is often difficult. Neurofilament light chain (NfL) is a component of the axonal cytoskeleton and identified as marker of neuronal damage in several CNS diseases. We evaluated the di
Externí odkaz:
https://doaj.org/article/421506f5cf37434cb2df70e74e76bcb5
Autor:
Elisabeth H. Thijssen, Inge M. W. Verberk, Jeroen Vanbrabant, Anne Koelewijn, Hans Heijst, Philip Scheltens, Wiesje van der Flier, Hugo Vanderstichele, Erik Stoops, Charlotte E. Teunissen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Plasma biomarkers that reflect specific amyloid beta (Abeta) proteoforms provide an insight in the treatment effects of Alzheimer’s disease (AD) therapies. Our aim was to develop and validate ready-to-use Simoa ‘Amyblood’ assays that m
Externí odkaz:
https://doaj.org/article/783c572408a54a5796b786b326983e7c
Autor:
Marie-Paule E van Engelen, Hans Heijst, Eline A J Willemse, Mardien L Oudega, Lisa Vermunt, Philip Scheltens, Everard G B Vijverberg, Yolande A L Pijnenburg, Charlotte E Teunissen
Publikováno v:
van Engelen, M-P E, Heijst, H, Willemse, E A J, Oudega, M L, Vermunt, L, Scheltens, P, Vijverberg, E G B, Pijnenburg, Y A L & Teunissen, C E 2023, ' Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases ', Brain Communications, vol. 5, no. 2, fcad120 . https://doi.org/10.1093/braincomms/fcad120
Brain Communications, 5(2):fcad120. Oxford University Press
Brain Communications, 5(2):fcad120. Oxford University Press
The clinical overlap of frontotemporal dementia and primary psychiatric diseases hampers diagnostic distinction, leading to frequent misdiagnosis and diagnostic delay. Neurofilament light chain has shown great potential in CSF and blood for the disti
Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy
Autor:
Birthe Roos, Marjo S. van der Knaap, Shanice Beerepoot, Charlotte E. Teunissen, Jaap Jan Boelens, Edwin H. Jacobs, Hans Heijst, Caroline A. Lindemans, Nicole I. Wolf, Mirjam M.C. Wamelink, Peter M. van Hasselt
Publikováno v:
Brain, 145(1), 105-118. Oxford University Press
Beerepoot, S, Heijst, H, Roos, B, Wamelink, M M C, Boelens, J J, Lindemans, C A, van Hasselt, P M, Jacobs, E H, van der Knaap, M S, Teunissen, C E & Wolf, N I 2022, ' Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy ', Brain, vol. 145, no. 1, pp. 105-118 . https://doi.org/10.1093/brain/awab304
Brain, 145(1), 105-118
Beerepoot, S, Heijst, H, Roos, B, Wamelink, M M C, Boelens, J J, Lindemans, C A, Van Hasselt, P M, Jacobs, E H, Van Der Knaap, M S, Teunissen, C E & Wolf, N I 2022, ' Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy ', Brain, vol. 145, no. 1, pp. 105-118 . https://doi.org/10.1093/brain/awab304
Beerepoot, S, Heijst, H, Roos, B, Wamelink, M M C, Boelens, J J, Lindemans, C A, van Hasselt, P M, Jacobs, E H, van der Knaap, M S, Teunissen, C E & Wolf, N I 2022, ' Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy ', Brain, vol. 145, no. 1, pp. 105-118 . https://doi.org/10.1093/brain/awab304
Brain, 145(1), 105-118
Beerepoot, S, Heijst, H, Roos, B, Wamelink, M M C, Boelens, J J, Lindemans, C A, Van Hasselt, P M, Jacobs, E H, Van Der Knaap, M S, Teunissen, C E & Wolf, N I 2022, ' Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy ', Brain, vol. 145, no. 1, pp. 105-118 . https://doi.org/10.1093/brain/awab304
Metachromatic leukodystrophy is a lethal metabolic leukodystrophy, with emerging treatments for early disease stages. Biomarkers to measure disease activity are required for clinical assessment and treatment follow-up. This retrospective study compar
Autor:
Marie‐Paule E. van Engelen, Hans Heijst, Eline A.J. Willemse, Mardien L Oudega, Lisa Vermunt, Philip Scheltens, Everard G.B. Vijverberg, Yolande A.L. Pijnenburg, Charlotte E. Teunissen
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Michelle Romijn, Emma M. Baas, Birgit I. Lissenberg-Witte, Wes Onland, Marsh Königs, Jaap Oosterlaan, Hans Heijst, Joost Rotteveel, Anton H. van Kaam, Charlotte E. Teunissen, Martijn J. J. Finken
Publikováno v:
Pediatric research. Lippincott Williams and Wilkins
Pediatric Research. Lippincott Williams and Wilkins
Romijn, M, Baas, E M, Lissenberg-Witte, B I, Onland, W, Königs, M, Oosterlaan, J, Heijst, H, Rotteveel, J, van Kaam, A H, Teunissen, C E & Finken, M J J 2022, ' Bronchopulmonary dysplasia is not related to neurofilament light for neuroaxonal damage in preterm infants ', Pediatric Research . https://doi.org/10.1038/s41390-022-02365-5
Pediatric Research. Lippincott Williams and Wilkins
Romijn, M, Baas, E M, Lissenberg-Witte, B I, Onland, W, Königs, M, Oosterlaan, J, Heijst, H, Rotteveel, J, van Kaam, A H, Teunissen, C E & Finken, M J J 2022, ' Bronchopulmonary dysplasia is not related to neurofilament light for neuroaxonal damage in preterm infants ', Pediatric Research . https://doi.org/10.1038/s41390-022-02365-5
Background: Neurofilament light (NfL) has been identified as a biomarker for neuroaxonal damage in preterm infants, but its relation with bronchopulmonary dysplasia (BPD) has not been established. We hypothesized that BPD is associated with increased
Autor:
Hans Heijst, Wiesje M. van der Flier, Charlotte E. Teunissen, Elisabeth H. Thijssen, Anne Mw. Koelewijn, Hugo Vanderstichele, Jeroen Vanbrabant, Erik Stoops, Philip Scheltens, Inge M.W. Verberk
Publikováno v:
Scientific Reports, 11(1):9736. Nature Publishing Group
Thijssen, E H, Verberk, I M W, Vanbrabant, J, Koelewijn, A, Heijst, H, Scheltens, P, van der Flier, W, Vanderstichele, H, Stoops, E & Teunissen, C E 2021, ' Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease ', Scientific Reports, vol. 11, no. 1, 9736 . https://doi.org/10.1038/s41598-021-89004-x
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Thijssen, E H, Verberk, I M W, Vanbrabant, J, Koelewijn, A, Heijst, H, Scheltens, P, van der Flier, W, Vanderstichele, H, Stoops, E & Teunissen, C E 2021, ' Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease ', Scientific Reports, vol. 11, no. 1, 9736 . https://doi.org/10.1038/s41598-021-89004-x
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
BACKGROUND Plasma biomarkers that reflect specific amyloid beta (Abeta) proteoforms are essential to monitor treatment effects of Alzheimer’s disease (AD) therapies. Our aim was to develop and validate ready-to-use Simoa ‘Amyblood’ assays that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a131ebfef2fe3d191b83b38cb28ebb04
https://research.vumc.nl/en/publications/bc000211-0b99-4eec-b898-ea9f2d121261
https://research.vumc.nl/en/publications/bc000211-0b99-4eec-b898-ea9f2d121261
Autor:
Bart N.M. van Berckel, Wiesje M. van der Flier, Hans Heijst, Niels D. Prins, Rosalinde E.R. Slot, Sander C.J. Verfaillie, Inge M.W. Verberk, Philip Scheltens, Charlotte E. Teunissen
Publikováno v:
Verberk, I M W, Slot, R E, Verfaillie, S C J, Heijst, H, Prins, N D, van Berckel, B N M, Scheltens, P, Teunissen, C E & van der Flier, W M 2018, ' Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes ', Annals of Neurology, vol. 84, no. 5, pp. 648-658 . https://doi.org/10.1002/ana.25334
Annals of Neurology, 84(5), 648-658. John Wiley and Sons Inc.
Annals of Neurology
Annals of Neurology, 84(5), 648-658. John Wiley and Sons Inc.
Annals of Neurology
Objective We investigated the association of plasma amyloid beta (Abeta)40, Abeta42, and total tau (tTau) with the presence of Alzheimer pathological changes in cognitively normal individuals with subjective cognitive decline (SCD). Methods We includ
Autor:
Hans Heijst, Elisabeth H. Thijssen, Charlotte E. Teunissen, Erik Stoops, Hugo Vanderstichele, Inge M.W. Verberk, Philip Scheltens
Publikováno v:
Alzheimer's & Dementia. 14